<?xml version="1.0" encoding="UTF-8"?>
<ref id="B92">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Dong</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>A.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). 
  <article-title>S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways</article-title>. 
  <source>Int. Immunopharmacol.</source>
  <volume>81</volume>, 
  <elocation-id>106273</elocation-id>. Â 
  <pub-id pub-id-type="doi">10.1016/j.intimp.20a20.106273</pub-id>
  <pub-id pub-id-type="pmid">32070920</pub-id>
 </mixed-citation>
</ref>
